跳至主要内容
临床试验/NCT01240265
NCT01240265已完成2 期

Maternal Oral Vitamin D Supplementation Via Daily or Monthly Regimens and the Effect on Levels of Vitamin D in Human Milk and Infant Serum

Mayo Clinic1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2010年12月1日最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
已完成
发起方
Mayo Clinic
入组人数
80
试验地点
1
主要终点
The number of days of detectable milk vitamin D concentrations

研究概览

简要总结

Adequate vitamin D is essential for proper infant growth and development. However, human milk is low in vitamin D, and most infants do not receive recommended supplementation. Our aim is to assess the feasibility of providing adequate vitamin D to breastfed infants through maternal vitamin D supplementation. Forty non-pregnant, lactating women at least 18 years of age with exclusively breastfed infants between the ages of 1 and 6 months will be randomized to receive oral vitamin D as either 5,000 IU daily for 28 days or 150,000 IU as a single dose. Maternal serum calcium, phosphorus, vitamin D and 25(OH)D; maternal urinary calcium; maternal milk vitamin D and 25(OH)D will be measured on days 0, 1, 3, 7, 14, and 28 of the study; and infant serum vitamin D and 25(OH)D will be measured on days 0 and 28.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
1 Month 至 50 Years(Child, Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Currently lactating mothers at least 18 years of age
  • •Willing to continue exclusively breastfeeding their infant throughout the study interval
  • •The infant is 1-6 months of age at the beginning of the study
  • •Willing and able to participate in all aspects of the study
  • •Mother and infant are in good health, as determined by the study investigator
  • •Have been provided with, understand, and have signed the informed consent for themselves and their child.

排除标准

  • •Have recently travelled (within the preceding 30 days) or plan to travel south of 35 degrees north latitude during the study interval
  • •Have recently or plan to engage in indoor tanning
  • •Are currently taking medications that affect vitamin D metabolism, like steroids, anticonvulsants, or barbiturates
  • •Are nursing multiple infants (e.g. twins)
  • •Are taking greater than the daily recommended intake of 1000 mg elemental calcium as calcium supplements
  • •Are taking greater than the standard daily dose of 400 IU of vitamin D found in prenatal vitamins
  • •Infant weight below 1.67 kg
  • •Mothers with baseline 25(OH)D levels >70 ng/ml, and/or infants with baseline 25(OH)D levels >70 ng/ml
  • •History of kidney stones

研究组 & 干预措施

Vitamin D 5000 units daily

Experimental

Vitamin D3 5000 IU daily given orally for 28 days

干预措施: Vitamin D3 (Dietary Supplement)

Vitamin D 150,000 units once

Experimental

Single dose of vitamin D3 150,000 IU given orally once

干预措施: Vitamin D3 (Dietary Supplement)

结局指标

主要结局

The number of days of detectable milk vitamin D concentrations

时间窗: 28 days

To compare the number of days of detectable milk vitamin D concentrations and incremental area under the curve between two dosing regimens of oral cholecalciferol in lactating mothers.

次要结局

  • Infant serum 25(OH)D concentration(28 days)

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Thomas Thacher

Consultant

Mayo Clinic

研究点 (1)

Loading locations...

相似试验